Kevin B Yankton's most recent trade in Twist Bioscience Corp was a trade of 70 Common Stock done at an average price of $13.0 . Disclosure was reported to the exchange on May 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.99 per share. | 17 May 2023 | 70 | 9,115 (0%) | 0% | 13.0 | 909 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.51 per share. | 10 Apr 2023 | 63 | 9,185 (0%) | 0% | 16.5 | 1,040 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.08 per share. | 31 Mar 2023 | 75 | 9,998 (0%) | 0% | 15.1 | 1,131 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.52 per share. | 17 Feb 2023 | 60 | 10,073 (0%) | 0% | 22.5 | 1,351 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.81 per share. | 03 Jan 2023 | 75 | 10,133 (0%) | 0% | 23.8 | 1,786 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 2,903 | 8,928 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.40 per share. | 17 Nov 2022 | 60 | 6,025 (0%) | 0% | 25.4 | 1,524 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 1,500 | 10,428 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. | 30 Sep 2022 | 220 | 10,208 (0%) | 0% | 35.2 | 7,753 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. | 30 Sep 2022 | 63 | 6,085 (0%) | 0% | 35.2 | 2,220 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.30 per share. | 17 Aug 2022 | 30 | 6,148 (0%) | 0% | 48.3 | 1,449 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.30 per share. | 17 Aug 2022 | 30 | 6,178 (0%) | 0% | 48.3 | 1,449 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.08 per share. | 01 Jul 2022 | 64 | 6,208 (0%) | 0% | 37.1 | 2,373 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.91 per share. | 17 May 2022 | 235 | 6,272 (0%) | 0% | 33.9 | 7,969 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.91 per share. | 01 Apr 2022 | 67 | 6,507 (0%) | 0% | 52.9 | 3,545 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.39 per share. | 09 Feb 2022 | 75 | 6,574 (0%) | 0% | 77.4 | 5,804 | Common Stock |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2021 | 3,448 | 6,649 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 2,551 | 2,551 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 1,600 | 3,201 (0%) | 0% | 0 | Common Stock | |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 22.66 per share. | 18 Feb 2021 | 956 | 0 (0%) | 0% | 22.7 | 21,663 | Common Stock |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 6,584 | 6,584 | - | - | Restricted Stock Units | |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 955 | 1,910 | - | - | Restricted Stock Units | |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 955 | 1,898 (0%) | 0% | 0 | Common Stock | |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 943 | 943 (0%) | 0% | 0 | Common Stock | |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 943 | 944 | - | - | Restricted Stock Units | |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.50 per share. | 12 Feb 2021 | 942 | 956 (0%) | 0% | 23.5 | 22,137 | Common Stock |
| Varex Imaging Corp | Kevin B Yankton | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 16.34 per share. | 20 Jul 2020 | 1,629 | 0 (0%) | 0% | 16.3 | 26,618 | Common Stock |